Non-Amyloid Approaches to Disease Modification for Alzheimer’s Disease: An EU/US CTAD Task Force Report

While amyloid-targeting therapies continue to predominate in the Alzheimer’s disease (AD) drug development pipeline, there is increasing recognition that to effectively treat the disease it may be necessary to target other mechanisms and pathways as well. In December 2019, The EU/US CTAD Task Force...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Prev Alzheimers Dis
Glavni autori: Gauthier, Serge, Aisen, P. S., Cummings, J., Detke, M. J., Longo, F. M., Raman, R., Sabbagh, M., Schneider, L., Tanzi, R., Tariot, P., Weiner, M., Touchon, J., Vellas, B.
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2020
Teme:
CTAD Task Force Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7223540/
https://ncbi.nlm.nih.gov/pubmed/32420298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14283/jpad.2020.18
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items